<DOC>
	<DOCNO>NCT01516593</DOCNO>
	<brief_summary>This multicenter , open-label trial evaluate activity safety investigational intensive HIV+ patient Burkitt 's lymphoma . Experimental treatment consist induction phase follow consolidation intensify phase accord tumor response . Until recently , immuno-compromised state patient concomitant HIV/AIDS BL think limit ability administer intensive chemotherapeutic regimen due infection rate . However , advent highly active antiretroviral therapy ( HAART ) evidence diffuse large B-cell lymphoma HIV-positive patient tolerate standard chemotherapeutic regimen improve outcomes lead investigator treat HIV-positive patient intensive chemotherapy regimen use treat immuno-competent patient . Data suggest current approach , along supportive care , may result improved patient outcome , similar immuno-competent patient population .</brief_summary>
	<brief_title>Short Term Intensified Chemo-immunotherapy HIV-positive Patients With Burkitt Lymphoma</brief_title>
	<detailed_description>The activity feasibility propose program assess HIV+ patient Burkitt lymphoma aim improve tolerability , minimize source consume support treatment redu ce late sequel . Available combination set really source demand toxic combination show high rate septic complication treatment-related mortality near 20 % .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Histologic diagnosis Burkitt 's lymphoma ( WHO 2008 ) HIV seropositivity Age ≥18 ≤60 year ECOGPS ≤3 CNS parenchymal involvement Absolute neutrophil count &lt; 1.000 cells/μL platelet count &lt; 75 × 109/L ( Burkitt unrelated ) Creatinine &gt; 1,5N ( Burkitt unrelated ) SGOT and/or SGTP &gt; 2,5N ( Burkitt unrelated ) Bilirubin &gt; 2N ( Burkitt unrelated ) Severe psychiatric illness clinical , social psychological condition could interfere patient 's adherence compliance Significant cardiac disease acute myocardial infarction last 12 month Severe active infection ( except HBV and/or HCV coinfection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Burkitt 's lymphoma</keyword>
	<keyword>intensive</keyword>
	<keyword>short term</keyword>
	<keyword>immuno-chemotherapy</keyword>
	<keyword>HIV-positive patient Burkitt 's lymphoma</keyword>
</DOC>